The causes of Parkinson’s disease are still largely a mystery.  Thomson Reuters has received a grant from The Michael J. Fox Foundation for Parkinson’s Research to create and publish the world’s most comprehensive source of biological maps for Parkinson’s disease.

The project aims to identify possible causes of Parkinson’s disease by mapping biological mutations of the Leucine-rich repeat kinase 2 (LRRK2) protein, the most common genetic contributor to the disease discovered to date. The maps trace the disease’s biological pathways to pinpoint relevant biomarkers, which are biological molecules that signal an abnormal process or disease. They also support the drug discovery process for treating PD.

Please follow and like us:
Pin Share